Key Trend Reshaping the NGS-Based RNA-Sequencing Market Share in 2025: Strategic Partnerships Driving Ngs-Based Rna Sequencing Market Share

What industry-specific factors are fueling the growth of the ngs-based rna-sequencing Market Share?
The surge in precision medication is propelling growth in the Market Share for NGS-based RNA sequencing. This type of medicine assists healthcare providers in tailoring treatment plans and making therapeutic choices based on genetic insights into the patient's ailment. For severe illnesses like cancer, there is an upswing in precision medication. NGS-based RNA sequencing facilitates the identification of the primary source of illness and the prescription of specific precision medication. For example, in February 2023, a report from the Personalized Medicine Coalition (PMC), a nonprofit organization based in the US, disclosed that personalized medications made up 35% of newly approved NMEs in 2021. Furthermore, with 12 new green lights in 2022, they have sustained a steady portion of at least one-fourth of new drug endorsements over the last eight years. This is a significant rise from less than 10% just ten years earlier. The requirement for NGS-based RNA sequencing is inline with the escalating demand for precision medication.

Get Your NGS-Based RNA-Sequencing Market Share Report Here:
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-Market Share-report

What Is the projected Market Share size and growth rate for the ngs-based rna-sequencing Market Share?
There has been a significant increase in the size of the NGS-based RNA-sequencing Market Share in the past few years. Predictions indicate that it will expand from $3.41 billion in 2024 to $4.23 billion in 2025, with a compound annual growth rate (CAGR) of 24.2%. The rise in this historic period is due to factors such as genomic research initiatives, lower sequencing costs, advances in drug discovery and development, personalized medicine, and increased NGS adoption.

The Market Share for NGS-based RNA-sequencing is projected to experience significant expansion in the ensuing years, reaching $10.4 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 25.2%. This predicted growth can be linked to various factors such as clinical diagnostics, worldwide collaborations, ethical and regulatory frameworks, as well as agricultural and environmental research, and green genomics. Key trends during the forecast period involve single-cell rna-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, multi-omics integration, and sustainable agriculture.

Get Your Free Sample Now - Explore Exclusive Market Share Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

What new trends are reshaping the ngs-based rna-sequencing Market Share and its opportunities?
The NGS-based RNA sequencing Market Share is seeing a significant trend in the form of strategic partnerships. Businesses are partnering with companies who specialize in NGS-based RNA sequencing in order to tap into new Market Shares and take advantage of mutual resources. For example, the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S Department of Health and Human Services, entered into a partnership with several industry and academic partners in May 2022. This was done with the aim of enhancing rapid response capabilities for public health emergencies and creating a new diagnostic tool. This tool would be able to detect every known and emerging respiratory RNA virus with just one test.

What major Market Share segments define the scope and growth of the ngs-based rna-sequencing Market Share?
The ngs-based rna-sequencing Market Share covered in this report is segmented -

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management
2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing
3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics
4) By End User: Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:
1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents
2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables
3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services
4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

Unlock Exclusive Market Share Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7416

Which region dominates the ngs-based rna-sequencing Market Share?
North America was the largest region in the NGS-based RNA sequencing Market Share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing Market Share report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which key Market Share leaders are driving the ngs-based rna-sequencing industry growth?
Major companies operating in the ngs-based rna-sequencing Market Share include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, Dickinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

Customize Your Report - Get Tailored Market Share Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

What Is Covered In The NGS-Based RNA-Sequencing Global Market Share Report?

•Market Share Size Forecast: Examine the ngs-based rna-sequencing Market Share size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the ngs-based rna-sequencing Market Share for a structured understanding.
•Key Players Overview: Analyze major players in the ngs-based rna-sequencing Market Share, including their Market Share value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the ngs-based rna-sequencing Market Share.
•Segment Contributions: Evaluate how different segments drive overall growth in the ngs-based rna-sequencing Market Share.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the ngs-based rna-sequencing Market Share.
•Industry Challenges: Identify potential risks and obstacles affecting the ngs-based rna-sequencing Market Share.
•Competitive Landscape: Review strategic developments in the ngs-based rna-sequencing Market Share, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.